Literature DB >> 11104789

Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene.

J Yun1, T Schöneberg, J Liu, A Schulz, C A Ecelbarger, D Promeneur, S Nielsen, H Sheng, A Grinberg, C Deng, J Wess.   

Abstract

The V2 vasopressin receptor (V2R) plays a key role in the maintenance of a normal body water balance. To generate an in vivo model that allows the physiological and molecular analysis of the role of V2Rs in kidney function, we have created mouse lines that lack functional V2Rs by using targeted mutagenesis in mouse embryonic stem cells. Specifically, we introduced a nonsense mutation known to cause X-linked nephrogenic diabetes insipidus (XNDI) in humans (Glu242stop) into the mouse genome. V2R-deficient hemizygous male pups showed a decrease in basal urine osmolalities and were unable to concentrate their urine. These pups also exhibited an enlargement of renal pelvic space, failed to thrive, and died within the first week after birth due to hypernatremic dehydration. Interestingly, female mice heterozygous for the V2R mutation showed normal growth but displayed an XNDI-like phenotype, characterized by reduced urine concentrating ability of the kidney, polyuria, and polydipsia. Western blot analysis and immunoelectron microscopic studies showed that the loss of functional V2Rs had no significant effect on the basal expression levels of aquaporin-2 and the bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1). The V2R mutant mice described here should serve as highly useful tools for the development of novel therapeutic strategies for the treatment of XNDI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104789      PMCID: PMC381460          DOI: 10.1172/JCI9154

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus.

Authors:  N Knoers; L A Monnens
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

2.  Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

Authors:  J P Morello; A Salahpour; A Laperrière; V Bernier; M F Arthus; M Lonergan; U Petäjä-Repo; S Angers; D Morin; D G Bichet; M Bouvier
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.

Authors:  A J Marchingo; J M Abrahams; E A Woodcock; A I Smith; F A Mendelsohn; C I Johnston
Journal:  Endocrinology       Date:  1988-04       Impact factor: 4.736

4.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

5.  Ontogenic development of antidiuretic hormone receptors in rat kidney: comparison of hormonal binding and adenylate cyclase activation.

Authors:  R M Rajerison; D Butlen; S Jard
Journal:  Mol Cell Endocrinol       Date:  1976-03       Impact factor: 4.102

Review 6.  Nephrogenic diabetes insipidus.

Authors:  N V Knoers; L L Monnens
Journal:  Semin Nephrol       Date:  1999-07       Impact factor: 5.299

7.  Vasopressin receptors in human seminal vesicles: identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney.

Authors:  M Maggi; E Baldi; A D Genazzani; S Giannini; A Natali; A Costantini; D Rodbard; M Serio
Journal:  J Androl       Date:  1989 Sep-Oct

8.  Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus.

Authors:  S J Lolait; A M O'Carroll; O W McBride; M Konig; A Morel; M J Brownstein
Journal:  Nature       Date:  1992-05-28       Impact factor: 49.962

9.  Molecular cloning of the receptor for human antidiuretic hormone.

Authors:  M Birnbaumer; A Seibold; S Gilbert; M Ishido; C Barberis; A Antaramian; P Brabet; W Rosenthal
Journal:  Nature       Date:  1992-05-28       Impact factor: 49.962

10.  The ontogeny of independent ingestion in mice: or, why won't infant mice feed?

Authors:  W G Hall; J A Browde
Journal:  Dev Psychobiol       Date:  1986-05       Impact factor: 3.038

View more
  28 in total

1.  AVR/NAVR deficiency lowers blood pressure and differentially affects urinary concentrating ability, cognition, and anxiety-like behavior in male and female mice.

Authors:  Victoria L M Herrera; Pia Bagamasbad; Julius L Decano; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 2.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

3.  AKAP220 manages apical actin networks that coordinate aquaporin-2 location and renal water reabsorption.

Authors:  Jennifer L Whiting; Leah Ogier; Katherine A Forbush; Paula Bucko; Janani Gopalan; Ole-Morten Seternes; Lorene K Langeberg; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-11       Impact factor: 11.205

4.  Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation.

Authors:  Bradley W McDill; Song-Zhe Li; Paul A Kovach; Li Ding; Feng Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

5.  UT-A urea transporter promoter, UT-Aalpha, targets principal cells of the renal inner medullary collecting duct.

Authors:  Robert A Fenton; Adetola Shodeinde; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-09

Review 6.  Unraveling the Physiology of (Pro)Renin Receptor in the Distal Nephron.

Authors:  Tianxin Yang
Journal:  Hypertension       Date:  2017-02-27       Impact factor: 10.190

7.  Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis.

Authors:  Melanie Ullrich; Karin Bundschu; Peter M Benz; Marco Abesser; Ruth Freudinger; Tobias Fischer; Julia Ullrich; Thomas Renné; Ulrich Walter; Kai Schuh
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

8.  Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.

Authors:  Baoxue Yang; Dan Zhao; A S Verkman
Journal:  FASEB J       Date:  2008-10-14       Impact factor: 5.191

9.  Expression patterns of the aquaporin gene family during renal development: influence of genetic variability.

Authors:  Kleber S Parreira; Huguette Debaix; Yvette Cnops; Lars Geffers; Olivier Devuyst
Journal:  Pflugers Arch       Date:  2009-04-16       Impact factor: 3.657

10.  Involvement of the V2 vasopressin receptor in adaptation to limited water supply.

Authors:  Iris Böselt; Holger Römpler; Thomas Hermsdorf; Doreen Thor; Wibke Busch; Angela Schulz; Torsten Schöneberg
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.